Back to Search
ALISON MESSER, MD
MD
Dermatology Physician
NPI: 1598129975IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
S4528(TX)
Dermatopathology Physician
Dermatology — Dermatopathology
Code: 207ND0900X
S4528(TX)
Education
OTHER
Class of 2016
Research & Publications (20)
Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.
PMID 19492089·PLoS One·2009
7-preclinical
Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.
PMID 19653865·Expert Opin Biol Ther·2009
6-review
Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.
PMID 18573260·J Mol Cell Cardiol·2008
4-observational
The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy.
PMID 18411228·Cardiovasc Res·2008
4-observational
Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease.
PMID 18199697·FASEB J·2008
7-preclinical
An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity.
PMID 18237741·J Mol Biol·2008
7-preclinical
Myofilament dysfunction in cardiac disease from mice to men.
PMID 19140019·J Muscle Res Cell Motil·2008
6-review
Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure.
PMID 17081561·J Mol Cell Cardiol·2007
8-other
Molecular characterization of the genetic lesion in Dystonia musculorum (dt-Alb) mice.
PMID 16725123·Brain Res·2007
7-preclinical
The therapeutic potential of intrabodies in neurologic disorders: focus on Huntington and Parkinson diseases.
PMID 17176119·BioDrugs·2006
6-review
Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies.
PMID 16061794·Proc Natl Acad Sci U S A·2005
4-observational
Intrabody applications in neurological disorders: progress and future prospects.
PMID 15964243·Mol Ther·2005
6-review
A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein.
PMID 15564134·Mol Ther·2004
7-preclinical
Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody.
PMID 15598740·Proc Natl Acad Sci U S A·2004
7-preclinical
Early postnatal Purkinje cells from staggerer mice undergo aberrant development in vitro with characteristic morphologic and gene expression abnormalities.
PMID 15351503·Brain Res Dev Brain Res·2004
7-preclinical
Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display.
PMID 15342245·J Mol Biol·2004
8-other
Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice.
PMID 15044061·Brain Res·2004
4-observational
Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
PMID 15005622·Biochemistry·2004
8-other
A single-chain Fv intrabody provides functional protection against the effects of mutant protein in an organotypic slice culture model of Huntington's disease.
PMID 14969746·Brain Res Mol Brain Res·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7979 WURZBACH RD BLDG 3
SAN ANTONIO, TX 78229 - Phone
- (210) 450-9840
Quick Facts
- NPI
- 1598129975
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile